InsidersTradesSigma
Browse the detailed record of transactions filed by Oliva Robert Letterio, Director. Director active across 1 companies, notably Novo Integrated Sciences, Inc.. Cumulatively, 1 reports have been logged. Total volume traded: €10k. The latest transaction was disclosed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Robert Letterio Oliva is a Board Member at Novo Integrated Sciences, Inc. He contributes to the governance of the company by providing strategic insights and overseeing operations. His experience in the life sciences sector is valuable to the organization.